Director/PDMR Shareholding


Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them

[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]

1   Details of the person discharging managerial responsibilities/person closely associated
a) Name   Mr Jason Hannon
2 Reason for the notification
a) Position/status Chief Executive Officer
b) Initial Notification Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Mainstay Medical International plc (the “Company”)
b) LEI 635400IUPSOZ26H56Y03
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument,

type of


Identification code

Ordinary Shares of nominal value of €0.001 each in the Company, ISIN: IE00BJYS1G50
b) Nature of the transaction Subscription for ordinary shares
c) Price(s) and volume(s)

 €14 per Ordinary Share

30,000 Ordinary Shares


d) Aggregated information

— Aggregated volume

— Price

Total price of the transaction: €420,000 (four hundred and twenty thousand euro)
e) Date of the transaction 15 February 2018
f) Place of the transaction Outside a trading venue
g) Additional Information N/A

Short Name: Mainstay Medical Intl. PLC
Category Code: DSH
Sequence Number: 641579
Time of Receipt (offset from UTC): 20180216T143558+0000


FTI Consulting for Mainstay Medical
Jonathan Neilan


FTI Consulting for Mainstay Medical
Jonathan Neilan